Literature DB >> 9704830

Herpes zoster in children.

T Kakourou1, M Theodoridou, G Mostrou, V Syriopoulou, H Papadogeorgaki, A Constantopoulos.   

Abstract

BACKGROUND: The clinical studies of series of children with herpes zoster (HZ) are rather limited.
OBJECTIVE: The purpose of this study was to evaluate the epidemiologic conditions, clinical manifestations, therapy, and outcome of HZ in children.
METHODS: Twenty-one patients with HZ have been studied. Five patients who had herpes simplex virus infection were excluded. The laboratory diagnosis was made by fluorescent techniques. Acyclovir was administered systematically for 2 more days after no new lesions had developed.
RESULTS: Thirteen patients (group A) were immunocompromised; eight patients (group B) were otherwise healthy. Two patients from group B had intrauterine varicella; the other six patients had had varicella under the age of 4 years. Three patients were recently exposed to varicella. The duration of HZ was significantly longer in group A than in group B, but the outcome was good in all patients.
CONCLUSION: Herpes simplex virus infection may simulate the pattern of HZ; varicella in early childhood is a risk factor for HZ in otherwise healthy children; exposure of a child to varicella may cause reactivation of latent HZ virus; and acyclovir therapy within 3 days of exanthem onset prevents significant morbidity and death in immunocompromised children with HZ.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704830     DOI: 10.1016/s0190-9622(98)70076-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  14 in total

1.  Shingles with secondary asymptomatic CNS involvement!

Authors:  Syed Viqar Ahmed; Hazim Hamada; Chaminda Jayawarna; Sumit Chandra
Journal:  BMJ Case Rep       Date:  2012-05-30

2.  Viral diseases of the skin: diagnosis and antiviral treatment.

Authors:  Zoltan Trizna
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 3.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 4.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

Review 5.  Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.

Authors:  D Gilden
Journal:  J Intern Med       Date:  2011-02-23       Impact factor: 8.989

6.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

Review 7.  Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Authors:  Niklaus H Mueller; Donald H Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

8.  [Zoster in infancy: report of a case].

Authors:  Kaoutar Zinelabidine; Meriame Meziane; Oufae Mikou; Fatima Zahra Mernissi
Journal:  Pan Afr Med J       Date:  2010-10-31

9.  Childhood herpes zoster: a clustering of ten cases.

Authors:  Smitha Prabhu; H Sripathi; Sanjeev Gupta; Mukyaprana Prabhu
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

10.  A 46-year-old female presenting with worsening headache, nuchal rigidity and a skin rash in varicella zoster virus meningitis: a case report.

Authors:  Anurag Kushawaha; Neville Mobarakai; Jill Tolia
Journal:  Cases J       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.